These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26395643)

  • 1. Coenzyme Q10 and oxidative stress, the association with peripheral sensory neuropathy and cardiovascular disease in type 2 diabetes mellitus.
    Forsberg E; Xu C; Grünler J; Frostegård J; Tekle M; Brismar K; Kärvestedt L
    J Diabetes Complications; 2015; 29(8):1152-8. PubMed ID: 26395643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes mellitus: correlation with glycemic control.
    El-ghoroury EA; Raslan HM; Badawy EA; El-Saaid GS; Agybi MH; Siam I; Salem SI
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):248-51. PubMed ID: 19530339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
    Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
    Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10.
    Zhang YP; Song CY; Yuan Y; Eber A; Rodriguez Y; Levitt RC; Takacs P; Yang Z; Goldberg R; Candiotti KA
    Neurobiol Dis; 2013 Oct; 58():169-78. PubMed ID: 23684663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus.
    Eriksson JG; Forsén TJ; Mortensen SA; Rohde M
    Biofactors; 1999; 9(2-4):315-8. PubMed ID: 10416046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes.
    ; Ahmad I; ; Ali M; Hussain M;
    J Pak Med Assoc; 2024 Aug; 74(8):1441-1448. PubMed ID: 39160710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes.
    Zhang YP; Eber A; Yuan Y; Yang Z; Rodriguez Y; Levitt RC; Takacs P; Candiotti KA
    Anesthesiology; 2013 Apr; 118(4):945-54. PubMed ID: 23334664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes.
    Sourris KC; Harcourt BE; Tang PH; Morley AL; Huynh K; Penfold SA; Coughlan MT; Cooper ME; Nguyen TV; Ritchie RH; Forbes JM
    Free Radic Biol Med; 2012 Feb; 52(3):716-723. PubMed ID: 22172526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress markers in hemodialysis and peritoneal dialysis patients, including coenzyme Q10 and ischemia-modified albumin.
    Mehmetoglu I; Yerlikaya FH; Kurban S; Erdem SS; Tonbul Z
    Int J Artif Organs; 2012 Mar; 35(3):226-32. PubMed ID: 22461118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
    Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
    Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Coenzyme Q10 Supplementation on Glucose Metabolism, Lipid Profiles, Inflammation, and Oxidative Stress in Patients With Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Gholnari T; Aghadavod E; Soleimani A; Hamidi GA; Sharifi N; Asemi Z
    J Am Coll Nutr; 2018; 37(3):188-193. PubMed ID: 29111905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between distal sensorimotor polyneuropathy and cardiovascular complications in diabetic patients in the North-Eastern region of Hungary.
    Pető A; Tóth LI; Hernyák M; Lőrincz H; Molnár Á; Nagy AC; Lukács M; Kempler P; Paragh G; Harangi M; Ferenc S
    PLoS One; 2024; 19(7):e0306482. PubMed ID: 38959204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
    Abdella N; Akanji AO; Mojiminiyi OA; Al Assoussi A; Moussa M
    Diabetes Res Clin Pract; 2000 Sep; 50(1):65-72. PubMed ID: 10936670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden.
    Kärvestedt L; Mårtensson E; Grill V; Elofsson S; von Wendt G; Hamsten A; Brismar K
    Diabetes Care; 2009 Feb; 32(2):317-22. PubMed ID: 19033412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity.
    Brauner H; Lüthje P; Grünler J; Ekberg NR; Dallner G; Brismar K; Brauner A
    Clin Exp Immunol; 2014 Aug; 177(2):478-82. PubMed ID: 24593795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia.
    Hasegawa G; Yamamoto Y; Zhi JG; Tanino Y; Yamasaki M; Yano M; Nakajima T; Fukui M; Yoshikawa T; Nakamura N
    Acta Diabetol; 2005 Dec; 42(4):179-81. PubMed ID: 16382305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms.
    West NA; Hamman RF; Mayer-Davis EJ; D'Agostino RB; Marcovina SM; Liese AD; Zeitler PS; Daniels SR; Dabelea D
    Diabetes Care; 2009 Jan; 32(1):175-80. PubMed ID: 18945923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
    Miyake Y; Shouzu A; Nishikawa M; Yonemoto T; Shimizu H; Omoto S; Hayakawa T; Inada M
    Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower body mass index is not of more benefit for diabetic complications.
    Zhang Y; Guo Y; Shen X; Zhao F; Yan S
    J Diabetes Investig; 2019 Sep; 10(5):1307-1317. PubMed ID: 30628186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.